Correction of hyperglycemia is therefore considered a priority of diabetes therapy and it has been pursued with drugs increasing insulin secretion and/or decreasing insulin resistance and obesity, a state of insulin resistance not only simply associated with diabetes but, more important, being a key factors linking T2DM and cardiovascular diseases (CV), the common clinical outcome of diabetes”. Here, INS is linked to Insulin resistance.